Search Results - "Yerramilli-Rao P"

Theme 09 - Clinical Trials and Trial Design.

Authors: Katz, J. Vu, T. Chiò, A. et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023 Suppl1, Vol. 24, p209-229. 21p.

Remote Wireless Oral Control of a Robotic Manipulator and a Powered Wheelchair, and Its Evaluation with Paralyzed Users.

Authors: Pálsdóttir, Ásgerður Arna Kæseler, Rasmus Leck Bentsen, Bo et al.

Source: Applied Sciences (2076-3417); Jul2026, Vol. 16 Issue 13, p6609, 18p

Mitigating the impact of study-start delays in clinical trials for rare disorders: insights and lessons from a PKAN trial.

Authors: Bracke, Marleen M. G. Polet, Sjoukje S. Plantinga, Mirjam et al.

Source: Orphanet Journal of Rare Diseases. 11/11/2025, Vol. 20 Issue 1, p1-13. 13p.

Age and life stage in the experience of amyotrophic lateral sclerosis: a scoping review.

Authors: Parks, Andrea S. E. Gotlib Conn, Lesley Amog, Krystle et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Feb2026, Vol. 27 Issue 1/2, p1-27. 27p.

A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma.

Authors: Bauer S Larkin J Hodi FS et al.

Source: Frontiers in oncology [Front Oncol] 2023 Jun 09; Vol. 12, pp. 975642. Date of Electronic Publication: 2023 Jun 09 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

This result is not displayed to guests.
Login for full access.

Impact of Platform Design and Usability on Adherence and Retention: Randomized Web- and Mobile-Based Longitudinal Study.

Authors: Jiang, Xinrui Timmons, Michelle Boroda, Elias et al.

Source: Journal of Participatory Medicine. 2025, Vol. 17, p1-12. 12p.

Experiences of acceptance and commitment therapy for people living with motor neuron disease (MND): a qualitative study from the perspective of people living with MND and therapists.

Source: Cognitive Behaviour Therapist. 2024, Vol. 17, p1-28. 28p.

MiNDAUS partnership: a roadmap for the cure and management of motor Neurone disease.

Authors: Vucic, Steve Wray, Naomi Henders, Anjali et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Aug2022, Vol. 23 Issue 5/6, p321-328. 8p.

Longitudinal comparison of the self-administered ALSFRS-RSE and ALSFRS-R as functional outcome measures in ALS.

Authors: Erb, M. Kelley Calcagno, Narghes Brown, Roland et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Aug2024, Vol. 25 Issue 5/6, p570-580. 11p.

Quality of life, cognitive and behavioural impairment in people with motor neuron disease: a systematic review.

Authors: Radakovic, Ratko Radakovic, Chelsea Abrahams, Sharon et al.

Source: Quality of Life Research. Jun2024, Vol. 33 Issue 6, p1469-1480. 12p.

Subjects: Motor neuron diseases, Burden of care, Neurodegeneration, Cognition disorders, Movement disorders

Health-Related Quality of Life, Psychological Health, and Patient-Reported Outcomes of Amyotrophic Lateral Sclerosis Patients in China.

Authors: Dhakal, Dilip Chen, Congzhou Zhang, Bo et al.

Source: Brain Sciences (2076-3425). Jul2025, Vol. 15 Issue 7, p696. 13p.

Current Therapies and Potential Strategies for Uveal Melanoma.

Authors: Scoles, Sarah Ganesh, Sanjay Yamada, Kaori H.

Source: Drugs & Drug Candidates. Jun2025, Vol. 4 Issue 2, p14. 24p.

Attrition and discontinuation in amyotrophic lateral sclerosis clinical trials: a meta-analysis.

Authors: van Eijk RPA van Loon FT van Unnik JWJ et al.

Source: Journal of neurology [J Neurol] 2024 Dec 12; Vol. 272 (1), pp. 40. Date of Electronic Publication: 2024 Dec 12.

Publication Type: Journal Article; Meta-Analysis; Systematic Review

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE

CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells.

Authors: Togashi, Keita Suzuki, Shuhei Mitobe, Yuta et al.

Source: Cancers. Jan2024, Vol. 16 Issue 1, p118. 12p.

Portable fixed dynamometry enables home-based, reliable assessment of muscle strength in patients with amyotrophic lateral sclerosis: a pilot study.

Authors: Van Unnik, Jordi W. J. Bakers, Jaap N.E. Kokx, Steure et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Nov2023, Vol. 24 Issue 7/8, p651-660. 10p.

Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis.

Authors: Babu, Suma Macklin, Eric A. Jackson, Katherine E. et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Feb2020, Vol. 21 Issue 1/2, p15-23. 9p.

Quality of life and depression in patients with amyotrophic lateral sclerosis – does the country of origin matter?

Authors: Ciećwierska, Katarzyna Lulé, Dorothée Bielecki, Maksymilian et al.

Source: BMC Palliative Care. 6/13/2023, Vol. 22 Issue 1, p1-11. 11p.

Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.

Authors: Young, C. A. Ealing, J. McDermott, C. J. et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Feb2023, Vol. 24 Issue 1/2, p82-90. 9p.

Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers—A Prospective, Cross-Sectional, Multi-Center Analysis.

Authors: Wohnrade, Camilla Velling, Ann-Kathrin Mix, Lucas et al.

Source: Brain Sciences (2076-3425). Jan2023, Vol. 13 Issue 1, p110. 24p.